Failures to disclose government funding associated with Doudna patents related to “Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
PDF version of letter to NIH. Failure2disclose-Doudna-patents-12oct2020 October 12, 2020 Michelle Bulls Director Office of Policy for Extramural Research Administration (OPERA) National Institutes of Health Via Email: michelle.bulls@nih.gov RE: Failures to disclose government funding associated with patents related to “Methods… Continue Reading